Exhibit 10.2
DATED
THIS DAY
OF 2008
BETWEEN
HAE SUNG CHANG - Shareholder #1
AND
PARK JAE KWON - Shareholder #2
AND
FIRST AMERICAN SCIENTIFIC CORPORATION
JOINT VENTURE & SHAREHOLDERS’ AGREEMENT
TABLE OF CONTENTS
4. ESTABLISHMENT
OF THE COMPANY
5. BUSINESS
OF THE COMPANY
5A. WARRANTIES AND
REPRESENTATIONS
6. CAPITAL
CALL & SHAREHOLDING
7. SHARE
CAPITAL OF THE COMPANY
8. UNDERTAKINGS
AND COVENANTS
9. OPERATIONS
OF THE COMPANY
12.
DIRECTORS’ RESERVED MATTERS
13.
GENERAL MEETINGS
14.
BUDGETS AND FINANCIAL INFORMATION
15. SHAREHOLDER
MATTERS
18. RIGHTS
TO INFORMATION AND CONFIDENTIALITY
TABLE OF CONTENTS
(cont.)
24.
PERFORMANCE OF AGREEMENT
25.
NAME
26.
NOTICES
|
|
GOVERNING LAW & JURISDICTION
|
36.
PREVALENCE OF AGREEMENT
37.
SPIRIT OF FAIRNESS AND EQUITY
|
|
|
SURVIVAL OF RIGHTS, DUTIES AND OBLIGATIONS
|
THIS AGREEMENT is made
this day
of 2004
|
|
JP FAS Korea Ltd. (Korean Company
Registration No. 110111-3890351) a private company with limited
liability duly incorporated and existing under the laws of Republic
of Korea, and having its place of business at
272-31,Nonhyun-Dong,Kangnam-Gu,Seoul Korea (in this Agreement
called FAS Korea),
|
|
|
FIRST AMERICAN SCIENTIFIC CORPORATION , a
USA a public company with limited liability duly incorporated
and existing under the laws of the Stae of Nevada, USA and having
its place of business at # 26 – 762 Vanyage Way, Delta BC,
Canada, V4G 1A6 (in this Agreement called “FASC”) of
the last part.
|
|
|
FAS Korea is in the business of sourcing,
developing and acquiring new technology for application in various
industries in Korea
|
|
|
FASC is an equipment manufacturer and provider
of turn-key systems and is the creator and owner of a patented
grinder-dryer technology called the “KDS Micronex Reduction
System” (in this Agreement called “ KDS Micronex
machine).
|
|
|
The parties have agreed to collaborate with
each other to carry on business in the area of selling and
marketing the KDS and to facilitate the same, have agreed to
establish a joint venture company in Korea .
|
|
|
The rights as shareholders of the joint
venture company shall be regulated by the provisions of this
Agreement and the Memorandum and Articles of Association of the
joint venture company.
|
|
|
(E) The parties have agreed that if any
conflict be found between this Agreement and Technical License
Agreement, the latter will govern.
|
|
|
In this Agreement, unless the context
otherwise requires, the following words and expressions shall have
the following meanings respectively:-
|
|
|
|
means the Companies Act of Korea;
|
|
|
|
means any company which is controlled by a
Shareholder or which is controlling or under the same control as a
Shareholder. For this purpose, control shall mean the direct or
indirect ownership of 50% or more of the shares entitled to
vote;
|
|
|
|
means the annual operating budget and any
other financial and investment plans approved by the Board under
Clause 14.1 and as may be amended from time to time;
|
|
|
|
means the Articles of Association for the time
being of the Company;
|
|
|
|
means the auditors for the time being of the
Company;
|
|
|
|
means the board of directors for the time
being of the Company;
|
|
|
|
has the meaning ascribed to it in Clause 5.2
and includes such other business as may be authorised pursuant to
the Business Plan;
|
|
|
|
means a day except a Saturday, Sunday or
public holiday (gazetted or ungazetted and whether scheduled or
unscheduled) on which banks are open for business in Korea.
|
|
|
|
means the business plan of the Company for a
specified period, which business plan shall specifically:-
|
|
|
describe the business objectives of the
Company for the specified period and the plans of the Company as to
how those objectives will be met;
|
|
|
estimate capital expenditure requirements
of the Company for the specified period;
|
|
|
estimate the profitability of the Company for
the specified period;
|
|
|
forecasting the balance sheet of the Company
as at the end of the specified period; and
|
|
|
addressing such other matters as the Board may
think appropriate.
|
|
|
means the chairman of the Board for the time
being;
|
|
|
“Chief Executive Officer”
|
has the meaning ascribed to it in Clause
11.1;
|
|
|
|
means the private company with limited
liability to be established by the Parties in Korea to undertake
the Business, as more particularly referred to in Clause 4;
|
|
|
|
has the meaning ascribed to it in section 2 of
the Securities Commission Act Korea;
|
|
|
|
means the directors for the time being of the
Company and the expression “Director” shall mean any of
them;
|
|
“Directors’ Reserved
Matters”
|
has the meaning ascribed to it in Clause
12.1;
|
|
|
|
means the value of the Company agreed by the
Shareholders, provided that if the Shareholders cannot agree, then
the Shareholders will jointly select an independent major
international accounting firm, or if the Shareholders fail to so
jointly select, the Auditors, to independently determine and
certify the value of the Company based on the Company’s net
tangible and intangible assets on a willing seller-willing buyer
basis;
|
|
|
|
means a financial year of the Company, which
as at the date of this Agreement has been fixed as ending on 30
June of each year, subject always to any change in Financial Year
end approved by the Board;
|
|
|
|
means First American Scientific
Corporation
|
|
|
|
means confidential information relating to a
Party or its business made available by it to any other Party (or
its representatives), whether before or after this Agreement is
entered into, for the purpose of considering, advising in relation
to or furthering the Business or for the performance of this
Agreement (and any information or analysis derived from such
information) and shall include all information relating to any
investment or potential investment and all reports, reviews and
strategies prepared for the Company in respect of its business;
|
|
|
|
means the budget as annexed hereto to Appendix
3 detailing the working capital requirements for the Company for
the period of 1 year from the date the Company commences
operations. For the purposes hereof, the Company “commences
operations” on the date the Company places its first order
for a KDS Micronex Machine from FASC for the demonstration plant in
Korea;
|
|
“Intellectual Property Rights”
|
means any and all intellectual and industrial
property rights throughout the world, including, without
limitation, rights in respect of, or in connection with:
(a) copyright (including future
copyright) and rights in the nature of or analogous to
copyright;
(b) inventions, discoveries;
(c) patents
and patent applications;
(d) trade
marks, service marks;
(e) designs, circuit layouts,
processes; and
(f) trade secrets and
know-how,
whether or not now existing and whether or not
registered and includes all future rights, any right to apply for
the registration of such rights and all renewals and extensions
thereof;
|
|
|
|
means the micronizing machine designed, the
specifications of which are annexed hereto to Appendix 2, and
includes all improvements thereto made by FASC from time to
time;
|
|
|
|
means the patented grinder-dryer micronizing
technology called the “KDS Micronex Reduction System”
utilised in the KDS Micronex Machine;
|
|
“Memorandum and
Articles
of Association”
|
means the memorandum and articles of
association for the time being of the Company;
|
|
|
|
means the ordinary shares of par value $50.00
USD each in the share capital of the Company (subject always to any
subdivision of the same), and the expression “Ordinary
Share” means an ordinary share in the capital of the
Company;
|
|
|
|
means collectively FAS Korea and FASC and any
other person becoming a party to this Agreement and the expression
“Party” shall refer to any one of them as
the context dictates;
|
|
|
|
means the ratio determined, immediately prior
to a proposed transfer, by dividing (i) the number of Ordinary
Shares held by the particular Shareholder (as a numerator) by (ii)
the total number of Ordinary Shares held by the Shareholders
excluding the number of Ordinary Shares held by the transferor
Shareholder undertaking the proposed transfer (as a
denominator);
|
|
|
|
means the ratio determined, immediately prior
to a proposed transfer, by dividing (i) the number of Ordinary
Shares held by the particular Shareholder (as a numerator) by (ii)
the total number of Ordinary Shares held by the Shareholders
excluding (a) the number of Ordinary Shares held by the transferor
Shareholder undertaking the proposed transfer and (b) the number of
Ordinary Shares held by the Shareholder(s) who have not accepted
their full entitlement of their Pro Rata Share (as a
denominator);
|
|
|
|
means the company secretary for the time being
of the Company;
|
|
|
has the meaning ascribed to it in Clause
15.1;
|
|
|
|
means the shares (whether ordinary or
preferred) in the share capital of the Company, and the expression
“Share” means a share in the capital of the
Company;
|
|
|
|
means the holders of Shares in the capital of
the Company and the expression “Shareholder” means a
person who is registered as a holder for the time being of Shares
in the capital of the Company and which person is a party to this
Agreement;
|
|
|
|
means any corporation which by virtue of
section 5 of the Act is deemed a subsidiary of the Company;
|
|
|
|
means any and all technology, technical
know-how, engineering techniques, experience, data, specifications,
processes, drawings, designs, programs, software, hardware,
database, proprietary rights, know-how and other material including
all improvements thereto and adaptations thereof;
|
|
|
|
means the lawful currency of the United States
of America.
|
|
|
The purpose of this Agreement is to set forth
the terms and conditions of the agreement and understanding reached
between the Parties in respect of the Company and the Business.
|
|
|
In consideration of the mutual agreements and
undertakings set out herein, the Shareholders have granted the
rights and accepted the obligations hereinafter appearing.
|
4.
ESTABLISHMENT OF THE COMPANY
|
|
The Parties agree that JP FAS Korea Ltd., a
private company with limited liability under the laws of Korea,
will be the Company used to undertake the business proposed
herein.
|
|
|
The Parties propose to rename the Company as
“First American Scientific Korea Ltd ) or in the
alternative as “FASC (Korea) Ltd In the event the
Registrar of Companies of not approve either of these
names, the Parties shall mutually agree in good faith on an
alternative suitable name of the Company.
|
|
|
The Business shall be conducted in the
Company’s best interests on sound commercial principles and
in accordance with good business practice and subject to the
provisions of this Agreement, the Memorandum and Articles of
Association and any applicable laws.
|
|
|
The Shareholders agree that the business of
the Company shall include the following (in this Agreement
collectively called “ the Business ”):-
|
5.2.1 manufacturing, operating, marketing and
selling the KDS in Korea
|
|
|
provision of servicing and maintenance for the
KDS in Korea
|
|
|
|
research and development of the KDS System and
the KDS Micronex Machine and other micronizing technology.
|
|
|
The Parties agree that all commercial
transactions between (i) the Company and (ii) any Shareholder or
its Affiliate, shall be at arms-length and bona fide for value and
any such transactions shall not be on terms or conditions more
favourable than would be extended to a non-related person.
|
|
|
The Business of the Company other than as may
be specifically referred to in this Agreement shall be detailed
from time to time in the Business Plan.
|
|
|
WARRANTIES AND
REPRESENTATIONS
|
5A.1
Each Party represents and warrants to the other Party
that:-
|
|
it is validly formed and existing under the
laws of the country of its incorporation;
|
|
|
it has the power and authority to enter and
lawfully perform this Agreement;
|
|
|
it has taken all necessary actions and passed
all necessary resolutions or taken all necessary steps, as the case
may be, to authorise the entry into and performance of this
Agreement including for the purposes of undertaking the obligations
contemplated by this Agreement;
|
5A.1.4 this
Agreement is legal and binding on such Party;
|
|
the execution, delivery and performance of
this Agreement, will not exceed the power granted to such Party by
or violate the provisions of:-
|
|
|
|
any law or regulation or any order or decree
of any governmental authority, agency or court to which it is
subject; or
|
|
|
|
its memorandum and articles of association or
other constitutive documents; and
|
|
|
it is not and will not be entitled to any
immunity from suit or other legal process in any proceedings in any
jurisdiction.
|
6.
CAPITAL CALL & SHAREHOLDING
|
|
Subject to Clause 6.2 and Clause 6.3, within
14 Business Days from the date of this Agreement or from the date
the Registrar of Companies of Korea approves the new name of the
Company, whichever date shall be later, ordinary stocks will be
distributed as below to each party
|
|
Shareholder
|
Number of Shares
|
Consideration payable
|
|
|
|
|
|
Hae
Sung Chang Shareholder1
|
2500
|
$125,000 USD
|
|
Jae
Kwon Park Shareholder2
|
2500
|
$125,000 USD
|
|
FASC
|
5000
|
$250,000 USD ( in kind)
|
|
|
The consideration payable by Shareholer 1 and
2 for their respective portions of the Initial Subscription shall
be cash
|
|
|
The consideration payable by FASC for its
portion of the Initial Subscription shall be a non-cash
consideration, through the grant by FASC to the Company of an
exclusive licence for the manufacturing, use, marketing and sale of
the KDS Micronex machine in Korea which licence is
valued at USD$250,000
|
|
|
SHARE CAPITAL OF THE COMPANY
|
|
|
The issued and paid-up share capital of the
Company shall be in the proportions referred to in Clause 6.4 and
unless otherwise altered pursuant to this Agreement, the
Shareholders' equity ratio in the Company so reflected shall be
maintained at all times as aforesaid.
|
|
|
If there is any increase in the paid-up share
capital of the Company, each Shareholder shall have the pre-emptive
right to subscribe for such further Shares in the applicable
proportions referred to in Clause 7.1.
|
8.
UNDERTAKINGS AND COVENANTS
8.1 SHAREHOLDER # 1 and
SHAREHOLDER # 2 undertake with FASC as follows:-
|
|
|
In addition to the required capital
contributions in Claise 6.1, SHAREHOLDER # 1 and SHAREHOLDER # 2
agree to provide cash advances as needed to the Company, from time
to time, up to enable the Company to meet its working capital
requirements in accordance with the Initial Budget. Such advances
shall be provided on an interest free basis and shall be repayable
by the Company to SHAREHOLDER # 1 or # 2 respectively once the
Company achieves positive cashflow.
|
|
|
|
that they will provide the expertise and
market links for the sale of the KDS in Korea to assist in the
development and expansion of the Business in Korea
|
8.2 FASC undertakes to
SHAREHOLDER # 1 and SHAREHOLDER # 2 as follows:-
|
|
|
that it will provide the Company with the
necessary Technology and expertise in the use and operation of the
KDS Micronex Machine;
|
|
|
|
to assist in the utilization of the technology
to the Company in respect of the KDS System on terms and conditions
to be agreed by the Parties; and
|
|
|
to assist in the development and expansion of
the Business.
|
|
|
The Parties agree that the Company shall:-
|
|
|
|
pay to FASC a royalty of $ 15,000 USD for each
KDS Micronex Machine manufactured and sold in Korea.
|
|
|
|
that SHAREHOLDER # 1 and SHAREHOLDER # 2 will
be entitled to be paid a commission by the Company for each KDS
Micronex Machine sold in Korea, the amount of which commission
shall be mutually agreed between the Parties.
|
|
|
As a material inducement to SHAREHOLDER # 1
and SHAREHOLDER # 2 to enter into this Agreement, FASC hereby
represents and warrants to SHAREHOLDER # 1 and SHAREHOLDER # 2
that:-
|
|
|
|
FASC is the owner of the patenetd KDS Micronex
Machine and the owner of the KDS System patents
|
|
|
|
it is not aware of any unsatisfied judgments,
orders or writs of execution that may affect the Intellectual
Property Rights in and to the KDS System and the KDS Micronex
Machine;
|
|
|
|
it has not granted any rights to any person
for the manufacture, use and sale of the KDS Micronex Machine in
Korea;
|
|
|
|
the KDS System, the KDS Micronex Machine and
all Intellectual Property Rights subsisting respectively therein do
not and will not infringe the Intellectual Property Rights of any
person and its exploitation does not and will not require any
consent from, nor the making of any payment to, any person other
than FASC;
|
|
|
|
the KDS System and the KDS Micronex Machine
and any Intellectual Property Rights subsisting respectively
therein have not been the subject of a claim by a third party based
on the infringements by the KDS System and the KDS Micronex Machine
on that party's Intellectual Property Rights prior to the date of
this Agreement, and no third party has threatened or is threatening
any infringement of this kind or has made or is making any claims
or has commenced or threatened to commence, or is commencing or
threatening to commence, any proceedings in relation to the KDS
System and/or the KDS Micronex Machine; and
|
|
|
|
the following applications for the
registration of patents in respect of the KDS System and the KDS
Micronex Machine have been duly filed with the relevant
bodies:-
|
USA
|
|
|
Patent application [No. 10/127,662] filed on
23 April 2002 with the United States Patent and Trademark Office.
Application approved and patent [No. 6,55,167 B2] has been granted
on 2 December 2003;
|
|
|
|
Patent application [No. 732979] filed on 19
October 1996 with the United States Patent and Trademark Office.
Application approved and patent [No. 5,839,671] has been granted on
24 February 1998;
|
|
|
|
Patent application [No. 197677] filed on 23
November 1998 with the United States Patent and Trademark Office.
Application approved and patent [No. 6,024,307] has been granted on
15 February 2000;
|
|
|
|
Patent application [No. 2,416,402] filed on 15
January 2003 with the Canadian Intellectual Property Office;
|
|
|
|
Patent application [No. 2,344,511] filed on 19
April 2001 with the Canadian Intellectual Property Office;
|
|
|
|
Patent application [No. CA 2218429] filed on
15 October 1997 with the Canadian Intellectual Property Office;
and
|
|
|
|
Patent application [No. 97944666.3-2313
0932446] filed on 16 October 1997 with the European Patent Office.
Application approved and patent [No. 0932446] granted.
|
|
|
Korean
Patent Application No. 10-2005-7009932
|
|
|
OPERATIONS OF THE COMPANY
|
|
|
The Shareholders agree to exercise their
respective rights as a shareholder of the Company and (insofar as
it lawfully can) to ensure that:-
|
|
|
|
the Company performs and complies with all
obligations on its part under this Agreement and complies with the
restrictions imposed upon it under the Articles; and
|
|
|
|
the Business is conducted in accordance with
law, sound and good business practice and the highest ethical
standards.
|
|
|
The Shareholders acknowledge and agree that
unless and until the Board decides otherwise, the business of the
Company shall be confined to the activities defined as Business in
this Agreement.
|
9.3 Solely for purposes of
obtaining a Korean patent, any new improvements to the Technology
may be patented in Korea only in the name of theCompany. This
patent may not be sold or transferred to a third party without the
express written consent of FASC. Should the Company
ceasebusiness or be discontinued for any reason whatsoever, or if
this agreement is breached, terminated or expires for any reason
whatsoever, the patent will be transferred back to FASC without
cost or recourse.
|
|
The affairs of the Company shall generally be
managed by a chief executive officer (in this Agreement called
“the Chief Executive Officer”), however, during the
first 5 years after the date of signing this agreement, unless
otherwise agreed by 100% of the shareholders, the
ordinary activities of the company will be managed jointly by
SHAREHOLDER # 1 and SHAREHOLDER # 2 who will report monthly the
members of the board.
|
|
|
The Chief Executive Officer shall, in
accordance with the directions and policies of the Board, be
responsible for the day-to-day management and operations of the
Company. The Chief Executive Officer shall act in accordance with
the directions of the Board and shall be responsible for such
matters as shall be delegated to him by the Board.
|
|
|
Commencing after the end of year five, each
Party shall, unless otherwise agreed by 100% of the shareholders,
have the right to nominate the candidate for the office of the
Chief Executive Officer. Notwithstanding the right to nominate such
candidate, each Party shall consult the other Parties prior to
nominating such candidate and submitting his candidature to the
Board for approval. The appointment of the Chief Executive Officer
shall require the approval of the Board.
|
|
|
Constitution of Board : The Parties
agree that the Board shall at all times consist of a maximum of
Four (4) Directors, of which SHAREHOLDER # 1 and SHAREHOLDER # 2
shall nominate one (1) each and FASC shall nominate two (2)
Directors.
|
|
|
Removal of Directors : The right to
nominate the Directors under Clause 11.1 shall include the
corresponding right from time to time to remove any nominee or
nominees and to substitute for another or others in his or their
place.
|
|
|
Appointment and Removal : Any
appointment or removal of a Director as aforesaid shall be made in
writing and be signed by or on behalf of the relevant Shareholder
and shall be delivered to the registered office for the time being
of the Company. Subject to Clauses 11.1 and 11.2, in order to give
effect to the provisions of this Clause 11, each of the
Shareholders shall exercise all its voting rights for the time
being in the Company to enable such Director(s) to be appointed.
Notwithstanding anything else to the contrary herein contained, a
Director shall cease to be a Director of the Company (and the
appointing Shareholder shall forthwith remove such Director) if
such Director:-
|
(i) becomes of
unsound mind;
|
|
|
is otherwise prevented from being a director
due to any statutory disqualification; or
|
|
|
|
the Shareholder appointing such Director shall
cease to hold any Shares in the Company.
|
|
|
Alternate Director : A Director shall
be entitled at any time and from time to time to appoint any person
to act as his alternate and to terminate the appointment of such
person and in that connection the provisions of the Articles shall
be complied with. Such alternate director shall be
entitled while holding office as such to receive notices of
meetings of the Board and to attend and vote as a Director at any
such meetings at which the Director appointing him is not present
and generally to exercise all the powers, rights, duties and
authorities and to perform all functions of his appointor in his
absence. Further, such alternate director shall be entitled to
exercise the vote of the Director appointing him at any meetings of
the Board and if such alternate director represents more than one
Director, such alternate director shall be entitled to one vote for
every Director he represents.
|
|
|
Chairman: The Chairman of the Board
shall be appointed by the Board. If the Chairman is not present at
any meeting of the Board or Shareholders, the Directors present
shall elect one amongst their number to act as the presiding
Chairman for the purpose of the meeting. The Chairman shall not
have a casting vote.
|
|
|
Quorum : All meetings of the Board
shall be convened and conducted in accordance with the provisions
of the Act and the Articles. The quorum for any meeting of the
Board shall be three (3) Directors or their alternates present in
person, provided that one of which shall be a Director nominated by
SHAREHOLDER # 1 and one a Director nominated by FASC, present at
the commencement of and throughout the meeting. If a quorum is not
present within 30 minutes from the time appointed for the holding
of a meeting of the Board when it is first convened, the meeting
shall be adjourned to the same day on the week next following at
the same time and place. At such adjourned meeting, any two (2)
Directors or their alternates present in person shall form a
quorum. If at such adjourned meeting such quorum is not constituted
within thirty (30) minutes of the time appointed for such adjourned
meeting, the said adjourned meeting shall be dissolved. Notice of
each adjourned meeting shall be given to all Directors. The agenda
of an adjourned meeting shall be the same as the agenda of the
original meeting which adjourned.
|
|
|
Meetings : Meetings of the Board shall
be held at such times as the Board shall determine. Provided that,
unless otherwise agreed by all the Directors, a meeting of the
Board shall be held at least once every quarter and more
frequently, if required. Not less than fourteen (14)
days notice (or such shorter period (not less than seven (7) days)
of notice in respect of any particular meeting as may be agreed by
all the Directors) of each meeting of the Board specifying the
date, place and time, of the meeting and the business to be
transacted thereat shall be given to all Directors. At each meeting
of the Board, each Director shall have the right to one (1) vote.
The Directors present at such meeting must exercise their voting
rights and cannot abstain from voting, except where required by law
or by any rules and regulations governing the conduct of the
Business. Subject to Clause 12, a resolution shall be deemed to
have been adopted by a simple majority vote in favour of the
resolution by the Directors present at the meeting, in person, or
by his alternate .
|
|
|
Resolutions in writing : A
resolution in writing circulated to all the Directors for the time
being and signed or approved by a majority of the Directors for the
time being by facsimile shall be as valid and effectual as if it
had been passed at a meeting of the Directors duly convened and
held. Any such re
|
|